Rabeprazole Sodium CAS 117976-90-6 Puritas >99.5% (HPLC) API Factory
Ruifu Chemical Supple Rabeprazole Sodium Intermedia
Rabeprazole Sodium CAS 117976-90-6
Rabeprazole Hydroxy Compone CAS 675198-19-3
Rabeprazole Chloride Compone CAS 153259-31-5
Nomen chemicum | Rabeprazole Sodium |
Synonyma | 2-([4-(3-Methoxypropoxy)-3-Methylpyridin-2-yl]methylsulfinyl)-1H-Benzo[d]imidazole;Pariprazole |
CAS Number | 117976-90-6 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C18H20N3NaO3S |
M. Pondus | 381.42 |
Liquescens punctum | 140.0~141.0℃ |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Crystallum vel pulveris luteum leviter pallidum;Hygroscopic |
Infrared Imaginis | Conformat ut Structure |
Proton NMR Spectrum | Conformat ut Structure |
ICP | Confirmat Sodium Component |
Solubilitas | Omnino solutum in aqua;Soluble in Ethanol, Chloroform;Solutum in Methanol |
pH | 9.5~12.0 |
Damnum in Siccatio | <1.00% |
Metalla gravis | <20ppm |
Substantiae cognatae | (HPLC) |
immunditiam A | <0.80% |
Impurities, non specificata | <0.20% |
Totalis immunditias | <1.00% |
RELICTUM Solvents | (GC) |
Methylene Chloride | <600ppm |
Ethanol | <5000ppm |
Isopropyl Ether | <5000ppm |
Acetone | <5000ppm |
Microbial Limit | |
Aerobe Comitis | ≤1000CFU/g* |
Fingunt et Yeasts Comitis | ≤100CFU/g* |
E. Coli | Abest per gram |
Puritas / Analysis Methodus | >99.5% (HPLC, Dried Basis) |
Test Standard | Enterprise Standard |
Consuetudinem | API pro Anti-ulcero |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Rabeprazole Sodium (CAS: 117976-90-6) est sentinae protonantis inhibitoris quae productionem stomachi in acido gastrico reprimit.Plures habet usus medicorum: administratio conditionum quae excessus productionis gastrici (ex. gr. Zollinger-Ellison syndrome), condiciones, quae ex acido gastrico (ex.g. ulcera tractu gastrointestinal) gravantur, et condiciones ad acidi gastrici longas expositionem pertinentes (eg. symptomatic gastroesophagi morbus refluxus).Rabeprazole etiam utilis est iuxta therationem antibioticam ad pathogen helicobacteri pylori curationem, quae aliter in ambitibus acidicis viget.Ita, Rabeprazole Sodium FDA approbatur ad tractationem symptomaticorum GERD in adulescentibus et adultis, ulceribus duodenalibus in adultis sanandis, pylori helicobacteri eradicatio, condiciones hypersecretoriae pathologicae.Rabeprazole Sodium productionem acidi in ventriculo supprimit, prohibendo H+/K+ATPase (hydrogen-potassium adenosinum triphosphatasum) apud secretorium superficiei cellulae parietalis gastrici.